doi:10.3969/j.issn.1671-2587.2023.01.002

JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE ›› 2023, Vol. 25 ›› Issue (1): 10-15.DOI: 10.3969/j.issn.1671-2587.2023.01.002

Previous Articles Next Articles

Received:2023-01-16 Published:2023-02-20

[1] World Health Organization. Aide-mémoire for ministries of health: National Haemovigilance System [EB/OL].(2015-01-01) https://www.who.int/publications/i/item/WHO-HIS-SDS-2015.10.
[2] World Health Organization. A guide to establishing a national haemovigilance system [EB/OL].( 2016-01-06) https://www.who.int/publications/i/item/9789241549844.
[3] World Health Organization. Action framework to advance universal access to safe, effective and quality-assured blood products2020-2023[EB/OL].(2020-02-19) https://www.who.int/publications/i/item/9789240000384.
[4] World Health Organization. Availability, safety and quality of blood products (WHA63.12) [EB/OL]. (2010-05-26) https://www.who.int/publications/i/item/WHA63.12.
[5] World Health Organization.User guide for navigating resources on stepwise implementation of haemovigilance systems[EB/OL]. (2022-07-15) https://www.who.int/publications/i/item/9789240047860.
[6] POLITIS C,WIERSUM J C,RICHARDSON C,et al.The International Haemovigilance Network Database for the Surveillance of Adverse Reactions and Events in Donors and Recipients of Blood Components:technical issues and results[J]. Vox Sang,2016,111(4):409-417.
[7] WHITAKER B I,BELOV A,ANDERSON S A.Progress in US hemovigilance:can we still learn from others?[J]. Transfusion,2019,59(2):433-436.
[8] ODAKA C,KATO H,OTSUBO H,et al.Online reporting system for transfusion-related adverse events to enhance recipient haemovigilance in Japan:a pilot study[J]. Transfus Apher Sci,2013,48(1):95-102.
[9] World Health Organization. Global status report on blood safety and availability2021 [EB/OL]. (2022-06-14) https://www.who.int/publications/i/item/9789240051683.
[10] Affiliated to the Royal College of Pathologists. The2019 Annual SHOT Report[EB/OL]. (2022-06-14)https://www.shotuk.org/wp-content/uploads/myimages/6.-Donor-Haemovigilance.pdf.
[11] National Agency for the Safety of Medicines and Health Products (ANSM). 2020 National Hemovigilance Report[EB/OL].(2021-12-08). https://ansm.sante.fr/uploads/2021/12/08/20211208-rapport-hemovigilance-2020-vf.pdf.
[12] National Blood Authority (NBA). Australian Haemovilance Report - Data for2018-2019 [EB/OL].(2021-07). https://www.blood.gov.au/system/files/documents/Australian-Haemovigilance-Report-2018-19-FINAL_v2.pdf.
[13] US Food & Drug Administration (FDA). Fatalities Reported to FDA Following Blood Collection and Transfusion [EB/OL].(2021-04-16). https://www.fda.gov/media/147628/download.
[14] The AABB US Donor Hemovigilance Working Group.2012 - 2014 AABB United States Donor Hemovigilance Report. [EB/OL]. https://www.aabb.org/docs/default-source/default-document-library/resources/2012-2014-aabb-donor-hemovigilance-report.pdf?sfvrsn=2b8be5b6_0.
[15] 中华人民共和国卫生部. 临床输血技术规范[S]. 2000.
[16] 中华人民共和国卫生部.血站质量管理规范[S] .2006.
[17] 中华人民共和国卫生部. 医疗机构临床用血管理办法[S].2012.
[18] 中华人民共和国国家卫生健康委员会. 临床用血质量控制指标(2019年版)[S].2019.
[19] 中华人民共和国国家卫生和计划生育委员会.献血不良反应分类指南[S]. 2017.
[20] 中华人民共和国国家卫生和计划生育委员会.献血相关血管迷走神经反应预防与处置指南[S].2018.
[21] 中华人民共和国国家卫生和计划生育委员会.输血反应分类指南[S].2018.
[22] 中华人民共和国国家卫生健康委员会.输血医学术语[S]. 2020.
[23] 国家卫生健康委.国家卫生健康委关于印发《全国血站服务体系建设发展规划(2021—2025年)》的通知[EB/OL].(2021-12-25). http://www.nhc.gov.cn/yzygj/s3589/202112/35bf5b087fd74ea08b0ee509978e4841.shtml.
[24] 中国输血协会.血液安全监测指南[S]. 2019.
[25] 中国输血协会血液安全监测专业委员会. 2020年全国血液安全监测报告 [EB/OL]. (2021-08-21).https://www.ccbc.org.cn/html/content/21/08/2179.shtml.
[26] 何涛. 中国输血行业发展报告(2019)[M]. 北京: 社会科学文献出版社,2019:1-21.
[27] Serious Hazards of Transfusion (SHOT) Steering Group. Annual SHOT Report2020 [EB/OL].(2021-07). https://www.shotuk.org/wp-content/uploads/myimages/SHOT-REPORT-2020.pdf.
[28] 埃里克.赫纳根. 安全-Ⅰ与安全-Ⅱ,安全管理的过去和未来[M]. 北京:中国工人出版社, 2015: 131.
[29] WOOD E M,ANG A L,BISHT A,et al.International haemovigilance:what have we learned and what do we need to do next?[J]. Transfus Med,2019,29(4):221-230.

RichHTML

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

About

Author

Journal

Access Statistics

Contact

[1]	XIE Dong-fu, Huang Xia, YANG Jun-hong, et al. Comparison and Analysis of Indicators Data from Domestic and International Haemovigilance Reports [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2023, 25(1): 16-20.
[2]	YANG Jun-hong, HU Wen-jie, YANG Pei, et al. Establishment and Evaluation of Hemovigilance Process for Adverse Reactions to Blood Donationin One Blood Center [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2023, 25(1): 21-25.
[3]	ZHU Wen-qin, CHEN Qi, ZENG Jia, et al. Analysis of the Sentinel Surveillance Data of Adverse Reactions to Whole Blood Donation in Fuzhou [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2023, 25(1): 26-32.
[4]	WANG Sheng-lan, GUI Ming-fei, HUA Min-yu, et al. Occurrence Times of Acute Transfusion Reactions [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2023, 25(1): 33-37.
[5]	ZHOU Shan-shan, JING Ya-nan, HOU Xiao-yan, et al. A Retrospective Analysis of 276 Adverse Transfusion Reactions in a Tertiary Hospital from 2021 to 2022 [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2023, 25(1): 38-43.
[6]	CHENG Zhi-xiang, REN Lin, CAO Hong-rong, et al. Haemovigilance for Guideline-based Blood Transfusion Adverse Events [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2023, 25(1): 48-55.
[7]	LI Jie, ZHANG Xue-rui, CHEN Zhong-ru, et al. Correction Effect of Platelets Preserved with Qingkailing Injections in Vitro Model of Massive Blood Loss [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2023, 25(1): 88-96.
[8]	WEN Pu-sheng, YANG Yuan-qi, PENG Xue-song, et al. Risk Factors of Massive Blood Transfusion in 140 Children with Living Donor Liver Transplantation [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2023, 25(1): 97-102.
[9]	. [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2023, 25(1): 103-106.
[10]	FENG Zhi-wen, YANG Jian, Huang Wei-wen, et al. Exploration for the Transfusion Threshold of Red Blood Cell in Hemodynamically Stable Patients with Non-variceal Upper Gastrointestinal Bleeding Based on Propensity Score Matching Method [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2023, 25(1): 107-111.
[11]	XIAO Guang-lin, WANG Ya, HUANG Jing, et al. Preliminary Analysis of the Influencing of Plasmapheresis Donation on Serum Ferritin Level and Iron Accumulation Rate in People at Risk of Iron Accumulation [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2023, 25(1): 112-118.
[12]	ZHAO Dong-yan, WANG Lin, TANG Ding-jie, et al. A Retrospective Study on the Inventory Management of Whole Blood and Red Blood Cell Components in Provincial Blood Collection and Supply Institutions in China [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2023, 25(1): 119-126.
[13]	ZHANG Yu, YE Sheng, RUI Xue, et al. Establishment of HLA and HPA Gene Database of Regular Platelet Donors in Nanjing Area [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2023, 25(1): 127-132.
[14]	DU Ya-li, ZHANG Rong, WANG Yan-ju, et al. Research Progress on the Anti-aging Effect of Young Plasma and its Mechanism [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2023, 25(1): 137-142.
[15]	LI Wan, WANG Ya, XIAO Guang-lin, et al. Research Progress in the Relationship of Apheresis Donation to Bone Metabolism and Bone Mineral Density [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2023, 25(1): 143-148.